Showing results (1-10 of 328) with videos related to

Sort By:
Pageof 33
Expert Opinion on Pharmacotherapy|November 13, 2015
Pharmacotherapeutic options for hepatitis BYi-Cheng Chen, Yun-Fan Liaw
Hepatology (Baltimore, Md.)|November 18, 2009
Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis BYi-Cheng Chen, Chia-Ming Chu, Yun-Fan Liaw
Hepatology International|August 12, 2009
Natural course following the onset of cirrhosis in patients with chronic hepatitis B: a long-term follow-up studyYi-Cheng Chen, Chia-Ming Chu, Chau-Ting Yeh, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 20, 2009
Withdrawal of lamivudine in HBeAg-positive chronic hepatitis B patients after achieving effective maintained virological suppressionChau-Ting Yeh, Chao-Wei Hsu, Yi-Cheng Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 7, 2011
Decreasing levels of HBsAg predict HBsAg seroclearance in patients with inactive chronic hepatitis B virus infectionYi-Cheng Chen, Wen-Juei Jeng, Chia-Ming Chu, et al.
The Journal of Antimicrobial Chemotherapy|March 4, 2016
α-Fetoprotein level-dependent early hepatitis B surface antigen decline during entecavir therapy in chronic hepatitis B with hepatitis flareWen-Juei Jeng, Yi-Cheng Chen, Ming-Ling Chang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 23, 2010
Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferaseChia-Ming Chu, Yi-Cheng Chen, Dar-In Tai, et al.
The American Journal of Gastroenterology|July 2, 2025
Switching to entecavir >3 months before the end of tenofovir-based therapy in HBeAg-negative patients may reduce early relapse and hepatitis flareYi-Cheng Chen, Wen-Juei Jeng, Rong-Nan Chien, et al.
Gastroenterology|October 3, 2002
Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infectionYi-Cheng Chen, I-Shyan Sheen, Chia-Ming Chu, et al.
Hepatology (Baltimore, Md.)|November 7, 2017
Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen-negative chronic hepatitis BWen-Juei Jeng, Yi-Cheng Chen, Rong-Nan Chien, et al.
Pageof 33